PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Nitroxoline→

Nitroxoline PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
4008-48-4
Molecular formula
C9H6N2O3
Molecular weight
190.16 g/mol
Drug class
8-hydroxyquinoline antibacterialurinary antiseptic
Mechanism of action
Chelates divalent metal ions required for bacterial enzyme activity and interferes with bacterial growth and biofilm formation. Its antimicrobial activity is concentrated in urine after renal excretion.
Indications / reported uses
  • Treatment of uncomplicated urinary-tract infections caused by susceptible organisms in countries where oral nitroxoline is authorised; local susceptibility and product label apply

Sources: NLM MeSH — Nitroxoline · PubMed — Nitroxoline urinary antiseptic clinical evidence · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Nitroxoline PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Nitroxoline Permitted Daily Exposure (PDE) report (the Nitroxoline PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Nitroxoline Occupational Exposure Limit (OEL) report (the Nitroxoline OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.